Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDepreciationExpense

Value{"unit": "CHF", "value": 122784}
Period2017-01-01 – 2017-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-20-009292
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/28158a66-55ab-4dce-9b9e-8129da55a694

History